Krsnaa Diagnostics Stock Screener | Share Price & Fundamental Analysis

Share Price NSE
₹642.10
▼ -7.10 (-1.09%)
2026-02-20 00:00:00
Share Price BSE
₹642.00
▼ -10.85 (-1.66%)
2026-02-20 00:00:00
Track Krsnaa Diagnostics share price live with TickJournal's free stock screener. Analyze Krsnaa Diagnostics share price history trends and compare 52-week high low levels. Calculate KRSNAA stock fair value using fundamental analysis and view live share price charts. Determine Krsnaa Diagnostics share intrinsic value and compare it with current KRSNAA share price. Record your Krsnaa Diagnostics trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹23.04
Dividend Yield 0.41%
Debt to Equity 0.21
Krsnaa Diagnostics 52 Week Low ₹634.10
Operating Margin 28.00%
Profit Margin 10.99%
EBITDA ₹57.00
Net Income ₹21.00
Total Assets ₹1,282.00
Total Equity ₹883.00

Krsnaa Diagnostics Share Price History - Stock Screener Chart

Screen KRSNAA historical share price movements with interactive charts. Analyze price trends and patterns.

Krsnaa Diagnostics Company Profile - Fundamental Screener

Screen Krsnaa Diagnostics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRSNAA shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE08LI01020

Krsnaa Diagnostics Balance Sheet Screener

Screen KRSNAA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022
Assets
Total Assets 1,282 1,172 910 876
Current Assets 415 421 223 334
Fixed Assets 670 647 471 386
Liabilities
Total Liabilities 1,282 1,172 910 876
Current Liabilities 93 81 72 71
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 883 810 739 684
Share Capital 16 16 16 16
Reserves & Surplus 867 794 723 669

Krsnaa Diagnostics Income Statement Screener - Profit & Revenue Analysis

Screen Krsnaa Diagnostics income statement and profit fundamentals. Analyze KRSNAA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Krsnaa Diagnostics share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 191 197 210 185 171 178 191 184 139 144 160 162 112 118 127
Expenses 133 142 147 135 123 128 137 129 99 108 124 121 80 85 92
EBITDA 57 55 63 50 48 50 54 54 40 36 36 42 32 32 35
Operating Profit % 28.00% 27.00% 29.00% 26.00% 26.00% 25.00% 27.00% 26.00% 26.00% 22.00% 20.00% 24.00% 26.00% 25.00% 25.00%
Depreciation 22 22 24 23 18 22 22 23 15 16 20 21 10 12 13
Interest 7 6 8 8 7 5 6 6 2 2 3 4 2 1 2
Profit Before Tax 29 27 32 20 23 23 25 26 24 18 13 16 20 19 20
Tax 8 7 8 4 4 5 6 6 5 3 3 3 2 5 5
Net Profit 21 21 24 15 19 18 20 19 19 15 11 13 18 14 15
EPS 6.40 6.35 7.38 4.72 5.80 5.55 6.07 6.01 6.03 4.66 3.35 4.09 5.40 4.53 5.73

Krsnaa Diagnostics Cash Flow Screener - Liquidity Fundamentals

Screen KRSNAA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2024-March 2023-March 2022-March 2017-March 2016-March
Operating Activities 24 76 128 64 -23
Investing Activities -129 -109 -241 -54 -47
Financing Activities 84 -33 176 -41 105
Net Cash Flow -20 -66 64 -31 36

Krsnaa Diagnostics Shareholding Pattern Screener

See Krsnaa Diagnostics shareholding pattern with promoter, FII, and DII holdings. Check Krsnaa Diagnostics promoter holding and ownership changes for KRSNAA on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 27.24% 27.11% 27.11% 27.11% 27.03% 27.17% 27.17% 27.24%
FII Holding 3.55% 3.40% 3.67% 4.17% 3.34% 3.33% 3.63% 4.04%
DII Holding 14.26% 14.24% 14.96% 13.86% 15.37% 15.26% 15.86% 14.46%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 29.13% 28.95% 27.40% 27.84% 27.72% 28.73% 28.41% 29.11%
Other Holding 25.81% 26.30% 26.86% 27.01% 26.54% 25.51% 24.94% 25.16%
Shareholder Count 53,559 54,262 52,117 52,380 56,458 55,914 53,519 52,799

Krsnaa Diagnostics Share Dividend Screener - Share Yield Analysis

Check Krsnaa Diagnostics dividend history with payout and yield data. View Krsnaa Diagnostics dividend details including ex-dates and amounts for KRSNAA stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹2.75 0.41%
2024-March ₹2.50 0.32%
2023-March ₹2.75 0.45%
2022-March ₹2.50 0.56%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Krsnaa Diagnostics Stock Index Membership

See which indices include Krsnaa Diagnostics stock. Check KRSNAA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.

Krsnaa Diagnostics Market Events Screener - Corporate Actions

Get Krsnaa Diagnostics corporate actions including splits, bonuses, and buybacks. Check Krsnaa Diagnostics stock events that may affect KRSNAA share price.
Announcement Date Record Date Event Type Information Price Impact
Dividend ₹ 2.75 /share 19.21%
Dividend ₹ 2.75 /share 29.48%
Dividend ₹ 2.50 /share 30.69%
Annual General Meeting NA 34.63%
Dividend ₹ 2.50 /share -2.35%
Annual General Meeting NA -2.35%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 2.01%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -5.32%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 1.72%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -0.98%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.19%
2024-10-25 2024-10-25 Quarterly Result Announcement NA -3.08%

Krsnaa Diagnostics Competitors Screener - Peer Comparison

Screen KRSNAA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 23,822 43.99 2,555 11.28% 492 43.51
Vijaya Diagnostic Centre 10,399 66.85 700 23.06% 144 49.38
Metropolis Healthcare 9,987 59.56 1,346 10.64% 146 52.68
Thyrocare Technologies 6,508 47.28 702 20.80% 91 38.76
Nephrocare Health Services 5,591 80.72 770 33.97% 67 69.85
Krsnaa Diagnostics 2,152 26.93 743 16.70% 78 34.08
One Global Service Provider 1,534 33.25 148 134.60% 19 73.28
Suraksha Diagnostic 1,484 45.68 256 15.11% 31 60.68
3B BlackBio DX 1,388 23.52 112 28.72% 48 50.92
Sastasundar Ventures 930 32.12 1,171 -18.47% -134 45.34

Krsnaa Diagnostics Company Announcements - News Screener

Screen KRSNAA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-02-17 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2026-02-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-02-13 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2026-02-12 Announcement under Regulation 30 (LODR)-Investor Presentation View
2026-02-12 List Of The Key Managerial PersonnelS (Kmps) For The Purpose Of Determining The Materiality Of An Event Or Information & Making Disclosures To The Stock Exchange(S). View
2026-02-12 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2026-02-12 Quarter And Nine Months Ended December 31 2025. View
2026-02-12 Board Meeting Outcome for Meeting Held On February 05 2026. View
2026-01-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-28 Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. View
2026-01-15 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) View
2026-01-14 Intimation Regarding Conversion Of Statutory Auditors Firm Into An LLP View
2026-01-07 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-07 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2026-01-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-27 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2025-12-26 Closure of Trading Window View
2025-12-12 Board Meeting Outcome for For Meeting Held On December 12 2025. View